天臣医疗 - Financials

天臣医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
+Revenue	272.0M	254.0M	232.0M	214.0M	163.0M	173.0M	119.0M	89.6M
Revenue Growth %	7.1%	9.5%	8.4%	31.3%	-5.8%	45.4%	32.7%	--
Total Revenue	272.0M	254.0M	232.0M	214.0M	163.0M	173.0M	119.0M	89.6M
Cost Of Revenue	113.0M	111.0M	99.1M	90.9M	68.1M	69.0M	49.2M	35.1M
+Gross Profit	159.0M	143.0M	132.9M	123.1M	94.9M	104.0M	69.8M	54.5M
Gross Margin %	58.5%	56.3%	57.3%	57.5%	58.2%	60.1%	58.6%	60.8%
Total Operating Cost	225.0M	218.0M	195.0M	181.0M	132.0M	128.0M	95.3M	76.1M
Selling Expenses	39.7M	41.6M	32.9M	36.9M	28.6M	30.6M	23.4M	24.2M
Admin Expenses	35.2M	30.5M	29.0M	25.9M	20.1M	13.4M	11.8M	8.5M
Rd Expenses	36.0M	35.3M	34.7M	29.3M	15.4M	14.1M	10.6M	8.2M
Finance Expenses	-2.2M	-4.7M	-4.0M	-4.6M	-1.9M	-1.2M	-1.2M	-911,800
+Operating Income	55.0M	46.4M	44.1M	44.9M	34.4M	45.1M	23.8M	13.7M
Operating Margin %	20.2%	18.3%	19.0%	21.0%	21.1%	26.1%	20.0%	15.2%
Non Operating Income	21,500	2.0M	2.2M	3.7M	6.1M	3.5M	3.4M	3.2M
Non Operating Expenses	187,300	509,800	218,800	2.5M	230,300	89,600	13,000	8,800
Investment Income	6.6M	5.6M	4.5M	10.5M	2.1M	39,400	99,000	128,100
Fair Value Change Income	-1.9M	4.1M	2.1M	435,300	557,800	--	--	--
Asset Disposal Income	--	1,600	47,300	520,200	5,400	--	--	--
Asset Impairment Loss	338,400	174,800	450,800	42,600	--	--	-116,200	-39,800
Other Income	2.8M	946,400	288,200	421,600	223,100	64,300	--	--
Income Before Tax	54.8M	47.9M	46.1M	46.1M	40.2M	48.6M	27.2M	16.9M
Income Tax	2.9M	636,100	2.9M	4.7M	5.3M	6.6M	4.0M	3.0M
+Net Income	51.9M	47.3M	43.2M	41.4M	34.9M	42.0M	23.1M	13.9M
Net Margin %	19.1%	18.6%	18.6%	19.4%	21.4%	24.3%	19.4%	15.5%
Net Income Attributable	51.9M	47.3M	43.2M	41.4M	34.9M	42.0M	23.1M	13.9M
Eps Basic	0.65	0.60	0.54	0.52	0.54	0.70	0.39	0.23
Eps Diluted	0.64	0.58	0.53	0.51	0.54	0.70	0.39	0.23

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash And Equivalents	64.1M	212.0M	33.1M	75.4M	127.0M	18.8M	18.5M	22.9M
Trading Financial Assets	331.0M	219.0M	329.0M	355.0M	253.0M	--	--	--
Accounts Receivable	12.5M	13.7M	7.9M	7.6M	3.2M	1.5M	1.8M	1.5M
Notes And Accounts Receivable	12.5M	13.7M	7.9M	7.6M	3.2M	1.5M	1.8M	1.5M
Prepayments	648,500	298,600	1.2M	313,400	232,800	496,500	296,400	37,300
Inventory	30.8M	29.2M	33.5M	26.3M	26.2M	27.1M	17.9M	16.2M
Total Current Assets	446.0M	475.0M	407.0M	466.0M	410.0M	49.4M	43.1M	41.9M
Fixed Assets	--	69.5M	71.0M	67.3M	69.6M	61.1M	64.5M	2.7M
Fixed Assets Total	71.0M	69.5M	71.0M	67.3M	69.6M	61.1M	64.5M	2.7M
Construction In Progress	--	13.9M	3.3M	5.1M	1.6M	10.8M	5.2M	49.5M
Construction In Progress Total	43.8M	13.9M	3.3M	5.1M	1.6M	10.8M	5.2M	49.5M
Intangible Assets	39.9M	40.2M	41.7M	3.0M	3.2M	3.4M	3.5M	3.8M
Long Term Deferred Expenses	200,600	131,100	94,300	25,100	3,700	39,100	55,300	71,500
Total Non Current Assets	192.0M	152.0M	136.0M	78.8M	75.0M	75.5M	73.8M	56.6M
Total Assets	637.0M	627.0M	543.0M	545.0M	485.0M	125.0M	117.0M	98.6M
Short Term Borrowings	--	--	--	--	--	--	9.0M	--
Accounts Payable	9.9M	12.9M	7.8M	8.7M	3.1M	6.5M	7.9M	8.2M
Advance Receipts	31,300	97,100	12,300	10,300	277,900	1.2M	798,700	492,600
Contract Liabilities	4.0M	16.6M	2.1M	3.5M	368,200	--	--	--
Total Current Liabilities	51.3M	51.0M	32.5M	30.8M	17.8M	16.6M	32.6M	17.0M
Total Non Current Liabilities	4.5M	4.1M	2.6M	1.9M	1.5M	1.1M	1.4M	1.7M
Total Liabilities	55.8M	55.1M	35.0M	32.7M	19.4M	17.7M	34.1M	18.7M
Paid In Capital	81.2M	81.2M	81.2M	80.0M	80.0M	60.0M	43.7M	43.7M
Capital Reserve	405.0M	413.0M	404.0M	371.0M	351.0M	46.9M	29.1M	29.1M
Surplus Reserve	22.4M	17.2M	13.0M	7.9M	3.7M	--	4.1M	1.6M
Retained Earnings	105.0M	98.2M	75.0M	52.7M	31.5M	178,000	6.2M	5.7M
Equity Attributable	581.0M	572.0M	508.0M	512.0M	466.0M	107.0M	82.9M	79.8M
Total Equity	581.0M	572.0M	508.0M	512.0M	466.0M	107.0M	82.9M	79.8M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash From Sales	288.0M	292.0M	256.0M	235.0M	180.0M	191.0M	136.0M	101.0M
Tax Refunds Received	4.8M	82,500	--	156,000	2.7M	611,900	276,300	179,600
Total Operating Cash Inflow	298.0M	297.0M	259.0M	240.0M	190.0M	195.0M	149.0M	109.0M
Cash Paid For Goods	123.0M	104.0M	114.0M	87.2M	74.6M	85.4M	56.4M	37.4M
Cash Paid To Employees	64.4M	61.3M	53.3M	48.5M	35.2M	33.1M	26.8M	25.2M
Taxes Paid	19.2M	17.9M	9.9M	15.5M	12.0M	13.4M	9.3M	8.2M
Total Operating Cash Outflow	245.0M	214.0M	208.0M	179.0M	148.0M	160.0M	114.0M	101.0M
Operating Cash Flow	53.4M	82.9M	50.4M	61.0M	42.1M	34.8M	34.4M	7.9M
Total Investing Cash Inflow	1.0B	664.0M	1.3B	1.2B	284.0M	14.3M	28.3M	43.3M
Total Investing Cash Outflow	1.2B	566.0M	1.4B	1.3B	541.0M	20.2M	52.0M	58.3M
Investing Cash Flow	-147.0M	98.0M	-29.2M	-101.0M	-257.0M	-5.9M	-23.7M	-15.0M
Cash From Borrowings	49.7M	--	37.3M	--	--	15.0M	22.0M	--
Dividends And Interest Paid	38.3M	19.8M	15.9M	16.0M	--	20.7M	18.0M	--
Debt Repayments	49.7M	--	37.3M	--	--	24.0M	13.0M	--
Total Financing Cash Inflow	76.9M	15.8M	51.3M	--	343.0M	15.0M	22.0M	--
Total Financing Cash Outflow	131.0M	20.5M	119.0M	16.0M	21.6M	44.7M	31.0M	--
Financing Cash Flow	-53.7M	-4.7M	-67.4M	-16.0M	321.0M	-29.7M	-9.0M	--
Net Change In Cash	-147.0M	178.0M	-42.4M	-51.4M	108.0M	884,100	3.3M	-6.4M
Ending Cash Balance	64.1M	212.0M	33.1M	75.4M	127.0M	18.8M	18.0M	14.7M
Capex	41.9M	18.4M	47.7M	9.2M	7.3M	9.4M	20.8M	15.2M